← Back to Search

Lu AF87908 for Alzheimer's Disease

Phase 1
Waitlist Available
Research Sponsored by H. Lundbeck A/S
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from day 0 to day 84
Awards & highlights

Study Summary

This trial is testing a new drug for safety and side effects in healthy people and people with Alzheimer's.

Eligible Conditions
  • Alzheimer's Disease
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from day 0 to day 84
This trial's timeline: 3 weeks for screening, Varies for treatment, and from day 0 to day 84 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AUC(0-t) of Lu AF87908
Cmax of Lu AF87908
Number of Participants with Treatment Emergent Adverse Events
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Part C: Lu AF87908 or PlaceboExperimental Treatment2 Interventions
Participants in Cohorts C1 and C4 will receive a single dose of either Lu AF87908 or matching placebo at specific dose levels on Day 1.
Group II: Part B: Lu AF87908 or PlaceboExperimental Treatment2 Interventions
Participants in Cohorts B1 to B3 will receive a single dose of either Lu AF87908 or matching placebo at specific dose levels on Day 1.
Group III: Part A: Lu AF87908 or PlaceboExperimental Treatment2 Interventions
Participants in Cohorts A1 to A6 will receive a single dose of either Lu AF87908 or matching placebo at specific dose levels on Day 1.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo
1995
Completed Phase 3
~2670
Lu AF87908
2019
Completed Phase 1
~90

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

H. Lundbeck A/SLead Sponsor
325 Previous Clinical Trials
77,497 Total Patients Enrolled
Email contact via H. Lundbeck A/SStudy DirectorLundbeckClinicalTrials@Lundbeck.com
188 Previous Clinical Trials
58,254 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent does Lu AF87908 pose a hazard for individuals?

"As Lu AF87908 is currently undergoing its first round of clinical trials, safety data is limited; thus our team at Power has rated this drug's safety a 1 on a scale from one to three."

Answered by AI

What is the geographic extent of this trial's implementation?

"In addition to the Atlanta, Hollywood, and Princeton locations, this clinical trial is also being administered at 4 other sites."

Answered by AI

Are participants currently being accepted into this experiment?

"Indeed, clinicaltrials.gov verifies that the study is presently recruiting patients, which started on September 27th 2019 with a latest edit being made on October 6th 2022. This medical trial necessitates 88 participants to be enrolled across 7 sites."

Answered by AI

What are the criteria for participating in this experiment?

"To meet the eligibility criteria of this clinical trial, participants must have Alzheimer's disease and be aged between 18 to 65. At present, 88 people are required for enrolment in this medical experiment."

Answered by AI

Are individuals above the age of twenty-five permitted to join this trial?

"This trial requires participants to be of age between 18 and 65. For those outside this range, there are 73 clinical trials for minors and 899 studies available for seniors."

Answered by AI

How many individuals have enrolled in this clinical trial?

"To complete the trial, 88 participants who satisfy the entry criteria must be enrolled. This study is supported by H. Lundbeck A/S and will take place at various facilities such as iResearch Atlanta LLC in Decatur, Georgia and Research Center of America in Hollywood, Florida."

Answered by AI

Who else is applying?

What state do they live in?
New York
New Jersey
Other
California
What site did they apply to?
PAREXEL International
Princeton Medical Institute
Other
California Clinical Trials Medical Group
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Have the gene for Alzheimer's. Local, I believe I qualify, and I need part time income.
PatientReceived 1 prior treatment
I'm interested in helping the progression of the medical industry. I’m interested in changing the world for the better and being part of a life changing moment.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease
2019. "Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04149860.
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top